Caption: Benign Prostatic Hyperplasia Treatment Market (Therapeutic Class - Alpha-blocker, Phosphodiesterase-5 Inhibitor, 5-alpha Reductase Inhibitor, and Other Therapeutic Class; Therapy - Mono Drug Therapy, and Combination Drug Therapy; End User - Hospitals
Credit: Infinium Global Research